Proposal for a new therapy for drug-resistant malaria using Plasmodium synthetic lethality inference

International Journal for Parasitology: Drugs and Drug Resistance

Volumn 3, Issue , 2013, Pages 119-128

  Lee, Sang Joon ^a   Seo, Eunseok ^a   Cho, Yonghyun ^b  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

^b Samsung SDS   (South Korea)

Author keywords

Antimalarial therapy; Drug targeting; Drug resistant malaria; Synthetic lethality

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ALVERINE CITRATE; ANTIMALARIAL AGENT; CASPOFUNGIN; CHLORMETHINE; FENPROPIMORPH; FLOXURIDINE; FLUCONAZOLE; FLUOROURACIL; FLUOROURIDINE; ITRACONAZOLE; METHOTREXATE; MICONAZOLE;

ANTIMALARIAL DRUG RESISTANCE; ARTICLE; BIOLOGICAL FUNCTIONS; BIOLOGICAL PHENOMENA AND FUNCTIONS CONCERNING THE ENTIRE ORGANISM; DRUG DESIGN; DRUG TARGETING; ENZYME BINDING; GENE IDENTIFICATION; GENETIC CONSERVATION; HUMAN; IN VIVO STUDY; LETHAL GENE; LETHALITY; MALARIA; MUTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMODIUM; PLASMODIUM (LIFE CYCLE STAGE); PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PRIORITY JOURNAL; PROTEIN DATA BANK; RELIABILITY; SACCHAROMYCES CEREVISIAE;

EID: 84880351275     PISSN: 22113207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpddr.2013.06.001     Document Type: Article

References (54)

1. Anderson T. Mapping the spread of malaria drug resistance. PLoS Med. 2009, 6(4):e1000054.
2. Baugh L.R., Wen J.C., Hill A.A., Slonim D.K., Brown E.L., Hunter C.P. Synthetic lethal analysis of Caenorhabditis elegans posterior embryonic patterning genes identifies conserved genetic interactions. Genome Biol. 2005, 6(5):r45.
3. Bernstein F.C., Koetzle T.F., Williams G.J., Meyer E.F., Brice M.D., Rodgers J.R., Kennard O., Shimanouchi T., Tasumi M. The Protein Data Bank: a computer-based archival file for macromolecular structures. J. Mol. Biol. 1977, 112(3):535-542.
4. Boone C., Bussey H., Andrews B.J. Exploring genetic interactions and networks with yeast. Nat. Rev. Genet. 2007, 8(6):437-449.
5. Briolant S., Bogreau H., Gil M., Bouchiba H., Baret E., Amalvict R., Rogier C., Pradines B. The F423Y mutation in the pfmdr2 gene and mutations N51I, C59R, and S108N in the pfdhfr gene are independently associated with pyrimethamine resistance in Plasmodium falciparum isolates. Antimicrob. Agents Chemother. 2012, 56:2750-2752.
6. Carlton J.M., Adams J.H., Silva J.C., Bidwell S.L., Lorenzi H., Caler E., Crabtree J., Angiuoli S.V., Merino E.F., Amedeo P., Cheng Q., Coulson R.M., Crabb B.S., Del Portillo H.A., Essien K., Feldblyum T.V., Fernandez-Becerra C., Gilson P.R., Gueye A.H., Guo X., Kang'a S., Kooij T.W., Korsinczky M., Meyer E.V., Nene V., Paulsen I., White O., Ralph S.A., Ren Q., Sargeant T.J., Salzberg S.L., Stoeckert C.J., Sullivan S.A., Yamamoto M.M., Hoffman S.L., Wortman J.R., Gardner M.J., Galinski M.R., Barnwell J.W., Fraser-Liggett C.M. Comparative genomics of the neglected human malaria parasite Plasmodium vivax. Nature 2008, 455(7214):757-763.
7. Chipman K., Singh A. Predicting genetic interactions with random walks on biological networks. BMC Bioinformatics 2009, 10:17.
8. Conde-Pueyo N., Munteanu A., Solé R.V., Rodríguez-Caso C. Human synthetic lethal inference as potential anti-cancer target gene detection. BMC Syst. Biol. 2009, 3:116.
9. Cowman A.F., Karcz S., Galatis D., Culvenor J.G. A P-glycoprotein homologue of Plasmodium falciparum is localized on the digestive vacuole. J. Cell Biol. 1991, 113:1033-1042.
10. Cowman A.F., Galatis D., Thompson J.K. Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross-resistance to halofantrine and quinine. Proc. Natl. Acad. Sci. USA 1994, 91:1143-1147.
11. Cox-Singh J., Davis T.M., Lee K.S., Shamsul S.S., Matusop A., Ratnam S., Rahman H.A., Conway D.J., Singh B. Plasmodium knowlesi malaria in humans is widely distributed and potentially life threatening. Clin. Infect. Dis. 2008, 46:165-171.
12. Dixon S.J., Fedyshyn Y., Koh J.L.Y., Prasad T.S.K., Chahwan C., Chua G., Toufighi K., Baryshnikova A., Hayles J., Hoe K.L., Kim D.U., Park H.O., Myers C.L., Pandey A., Durocher D., Andrews B.J., Boone C. Significant conservation of synthetic lethal genetic interaction networks between distantly related eukaryotes. Proc. Natl. Acad. Sci. USA 2008, 105(43):16653-16658.
13. Eisenstein M. Drug development: holding out for reinforcements. Nature 2012, 484:s16-s18.
14. Fernández A., Crespo A., Tiwari A. Is there a case for selectively promiscuous anticancer drugs?. Drug Discov. Today 2009, 14(1-2):1-5.
15. Foote S.J., Kyle D.E., Martin R.K., Oduola A.M., Forsyth K., Kemp D.J., Cowman A.F. Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum. Nature 1990, 345:255-258.
16. Forsburg S.L. The art and design of genetic screens: yeast. Nat. Rev. Genet. 2001, 2(9):659-668.
17. Gardner M.J., Hall N., Fung E., White O., Berriman M., Hyman R.W., Carlton J.M., Pain A., Nelson K.E., Bowman S., Paulsen I.T., James K., Eisen J.A., Rutherford K., Salzberg S.L., Craig A., Kyes S., Chan M.S., Nene V., Shallom S.J., Suh B., Peterson J., Angiuoli S., Pertea M., Allen J., Selengut J., Haft D., Mather M.W., Vaidya A.B., Martin D.M., Fairlamb A.H., Fraunholz M.J., Roos D.S., Ralph S.A., McFadden G.I., Cummings L.M., Subramanian G.M., Mungall C., Venter J.C., Carucci D.J., Hoffman S.L., Newbold C., Davis R.W., Fraser C.M., Barrell B. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 2002, 419:498-511.
18. Giancarlo A.B., Patrick G.B., Stephen A.W.D.L. Mechanisms of antimalarial drug resistance. Antimicrobial Drug Resistance 2009, 561-574. Humana Press, New York. D.L. Mayers (Ed.).
19. Goh K.I., Cusick M.E., Valle D., Childs B., Vidal M., Barabási A.L. The human disease network. Proc. Natl. Acad. Sci. USA 2007, 104(21):8685-8690.
20. Hillenmeyer M.E., Fung E., Wildenhain J., Pierce S.E., Hoon S., Lee W., Proctor M., St Onge R.P., Tyers M., Koller D., Altman R.B., Davis R.W., Nislow C., Giaever G. The chemical genomic portrait of yeast: uncovering a phenotype for all genes. Science 2008, 320(5874):362-365.
21. Hillenmeyer M.E., Ericson E., Davis R.W., Nislow C., Koller D., Giaever G. Systematic analysis of genome-wide fitness data in yeast reveals novel gene function and drug action. Genome Biol. 2010, 11(3):r30.
22. Huthmacher C., Hoppe A., Bulik S., Holzhütter H.G. Antimalarial drug targets in Plasmodium falciparum predicted by stage-specific metabolic network analysis. BMC Syst. Biol. 2010, 4:120.
23. Itoh M., Akutsu T., Kanehisa M. Clustering of database sequences for fast homology search using upper bounds on alignment score. Genome Inform. 2004, 15(1):93-104.
24. Jorgensen E.M., Mango S.E. The art and design of genetic screens: Caenorhabditis elegans. Nat. Rev. Genet. 2002, 3(5):356-369.
25. Knox C., Law V., Jewison T., Liu P., Ly S., Frolkis A., Pon A., Banco K., Mak C., Neveu V., Djoumbou Y., Eisner R., Guo A.C., Wishart D.S. DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res. 2011, 39:D1035-D1041.
26. Lehner B., Crombie C., Tischler J., Fortunato A., Fraser A.G. Systematic mapping of genetic interactions in Caenorhabditis elegans identifies common modifiers of diverse signaling pathways. Nat. Genet. 2006, 38(8):896-903.
27. Maere S., Heymans K., Kuiper M. Bingo: a cytoscape plugging to assess over-representation of gene ontology categories in biological networks. Bioinformatics 2005, 21(16):3448-3449.
28. Mutabingwa T., Nzila A., Mberu E., Nduati E., Winstanley P., Hills E., Watkins W. Chlorproguanil-dapsone for treatment of drug- resistant falciparum malaria in Tanzania. Lancet 2001, 358:1218-1223.
29. Nakaya A., Katayama T., Itoh M., Hiranuka K., Kawashima S., Moriya Y., Okuda S., Tanaka M., Tokimatsu T., Yamanishi Y., Yoshizawa A.C., Kanehisa M., Goto S. KEGG OC: a large-scale automatic construction of taxonomy-based ortholog clusters. Nucleic Acids Res. 2013, 41:D353-D357.
30. Noguchi T., Akiyama Y. PDB-REPRDB: a database of representative protein chains from the Protein Data Bank (PDB) in 2003. Nucleic Acids Res. 2003, 31(1):492-493.
31. Ooi S.L., Pan X., Peyser B.D., Ye P., Meluh P.B., Yuan D.S., Irizarry R.A., Bader J.S., Spencer F.A., Boeke J.D. Global synthetic-lethality analysis and yeast functional profiling. Trends Genet. 2006, 22:56-63.
32. Paladugu S.R., Zhao S., Ray A., Raval A. Mining protein networks for synthetic genetic interactions. BMC Bioinformatics 2008, 9:426.
33. Pan X., Yuan D.S., Xiang D., Wang X., Sookhai-Mahadeo S., Bader J.S., Hieter P., Spencer F., Boeke J.D. A robust toolkit for functional profiling of the yeast genome. Mol. Cell. 2004, 16(3):487-496.
34. Peel S.A., Merritt S.C., Handy J., Baric R.S. Derivation of highly mefloquine-resistant lines from Plasmodium falciparum in vitro. Am. J. Trop. Med. Hyg. 1993, 48:385-397.
35. Peel S.A., Bright P., Yount B., Handy J., Baric R.S. A strong association between mefloquine and halofantrine resistance and amplification, overexpression, and mutation in the P-glycoprotein gene homolog (pfmdr) of Plasmodium falciparum in vitro. Am. J. Trop. Med. Hyg. 1994, 51:648-658.
36. Platzer A., Perco P., Lukas A., Mayer B. Characterization of protein-interaction networks in tumors. BMC Bioinformatics 2007, 8:224.
37. Price R.N., Tjitra E., Guerra C.A., Yeung S., White N.J., Anstey N.M. Vivax malaria: neglected and not benign. Am. J. Trop. Med. Hyg. 2007, 77:79-87.
38. Reed M.B., Saliba K.J., Caruana S.R., Kirk K., Cowman A.F. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature 2000, 403:906-909.
39. Rozmajzl P.J., Kimura M., Woodrow C.J., Krishna S., Meade J.C. Characterization of P-type ATPase 3 in Plasmodium falciparum. Mol. Biochem. Parasitol. 2001, 116(2):117-126.
40. Rubio J.P., Cowman A.F. The ATP-binding cassette (ABC) gene family of Plasmodium falciparum. Parasitol. Today 1996, 12:135-140.
41. Schlatter I.D., Meira M., Ueberschlag V., Hoepfner D., Movva R., Hynes N.E. MHO1, an evolutionarily conserved gene, is synthetic lethal with PLC1; Mho1p has a role in invasive growth. PLoS One 2012, 7(3):e32501.
42. Shannon P., Markiel A., Ozier O., Baliga N.S., Wang J.T., Ramage D., Amin N., Schwikowski B., Ideker T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003, 13(11):2498-2504.
43. Sibley C.H., Hyde J.E., Sims P.F., Plowe C.V., Kublin J.G., Mberu E.K., Cowman A.F., Winstanley P.A., Watkins W.M., Nzila A.M. Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next?. Trends Parasitol. 2001, 17:582-588.
44. Sonnhammer E.L.L., Koonin E.V. Orthology, paralogy and proposed classification for paralog subtypes. Trends Genet. 2002, 18(12):619-620.
45. Tarailo M., Tarailo S., Rose A.M. Synthetic lethal interactions identify phenotypic "interologs" of the spindle assembly checkpoint components. Genetics 2007, 177(4):2525-2530.
46. Tischler J., Lehner B., Fraser A.G. Evolutionary plasticity of genetic interaction networks. Nat. Genet. 2008, 40(4):390-391.
47. Tong A.H., Evangelista M., Parsons A.B., Xu H., Bader G.D., Pagé N., Robinson M., Raghibizadeh S., Hogue C.W., Bussey H., Andrews B., Tyers M., Boone C. Systematic genetic analysis with ordered arrays of yeast deletion mutants. Science 2001, 294(5550):2364-2368.
48. Tong A.H.Y., Lesage G., Bader G.D., Ding H., Xu H., Xin X., Young J., Berriz G.F., Brost R.L., Chang M., Chen Y., Cheng X., Chua G., Friesen H., Goldberg D.S., Haynes J., Humphries C., He G., Hussein S., Ke L., Krogan N., Li Z., Levinson J.N., Lu H., Ménard P., Munyana C., Parsons A.B., Ryan O., Tonikian R., Roberts T., Sdicu A.M., Shapiro J., Sheikh B., Suter B., Wong S.L., Zhang L.V., Zhu H., Burd C.G., Munro S., Sander C., Rine J., Greenblatt J., Peter M., Bretscher A., Bell G., Roth F.P., Brown G.W., Andrews B., Bussey H., Boone C. Global mapping of the yeast genetic interaction network. Science 2004, 303(5659):808-813.
49. Wellems T.E., Panton L.J., Gluzman I.Y., Rosario V.E., Gwadz R.W., Walker-Jonah A., Krogstad D.J. Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross. Nature 1990, 345:253-255.
50. Wilson C.M., Serrano A.E., Wasley A., Bogenschutz M.P., Shankar A.H., Wirth D.F. Amplification of a gene related to mammalian mdr genes in drug-resistant Plasmodium falciparum. Science 1989, 244:1184-1186.
51. Yeh I., Hanekamp T., Tsoka S., Karp P.D., Altman R.B. Computational analysis of Plasmodium falciparum metabolism: organizing genomic information to facilitate drug discovery. Genome Res. 2004, 14:917-924.
52. Yildirim M.A., Goh K.I., Cusick M.E., Barabási A.L., Vidal M. Drug-target network. Nat. Biotechnol. 2007, 25:1119-1126.
53. Yuen K.W.Y., Warren C.D., Chen O., Kwok T., Hieter P., Spencer F.A. Systematic genome instability screens in yeast and their potential relevance to cancer. Proc. Natl. Acad. Sci. USA 2007, 104(10):3925-3930.
54. Zalis M.G., Wilson C.M., Zhang Y., Wirth D.F. Characterization of the pfmdr2 gene for Plasmodium falciparum. Mol. Biochem. Parasitol. 1993, 62:83-92.